APA (7th ed.) Citation

C, L., JS, C., I, K., KT, O., ES, L., ES, P., . . . YS, Y. (2013). Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes. Dove Medical Press.

Chicago Style (17th ed.) Citation

C, Lee, Choi JS, Kim I, Oh KT, Lee ES, Park ES, Lee KC, and Youn YS. Long-acting Inhalable Chitosan-coated Poly(lactic-co-glycolic Acid) Nanoparticles Containing Hydrophobically Modified Exendin-4 for Treating Type 2 Diabetes. Dove Medical Press, 2013.

MLA (8th ed.) Citation

C, Lee, et al. Long-acting Inhalable Chitosan-coated Poly(lactic-co-glycolic Acid) Nanoparticles Containing Hydrophobically Modified Exendin-4 for Treating Type 2 Diabetes. Dove Medical Press, 2013.